Basic Information | Post buying leads | Suppliers |
Name |
VERODOXIN |
EINECS | N/A |
CAS No. | 6875-10-1 | Density | 1.31g/cm3 |
PSA | 140.98000 | LogP | 2.89760 |
Solubility | N/A | Melting Point |
197.5°C |
Formula | C31H46O10 | Boiling Point | 734.5°Cat760mmHg |
Molecular Weight | 578.7 | Flash Point | 233.7°C |
Transport Information | N/A | Appearance | N/A |
Safety | Poison by ingestion, subcutaneous, and intravenous routes. | Risk Codes | N/A |
Molecular Structure | Hazard Symbols | N/A | |
Synonyms |
Strospeside,16-formate;EINECS 229-976-8;Verodoxin;Gitaloxigenin + digitalose; |
IUPAC Name: [3-(3,5-dihydroxy-4-methoxy-6-methyloxan-2-yl)oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] formate
Synonyms of Verodoxin (CAS NO.6875-10-1): 3β-[(3-O-Methyl-6-deoxy-D-galactopyranosyl)oxy]-16β-(formyloxy)-14-hydroxy-5β-card-20(22)-enolide ; Strospeside 16-formate
Index of Refraction: 1.582
Density: 1.31 g/cm3
Flash Point: 233.7 °C
Surface Tension: 58 dyne/cm
Boiling Point: 734.5 °C at 760 mmHg
Enthalpy of Vaporization: 122.37 kJ/mol
Vapour Pressure: 6.63E-25 mmHg at 25°C
Molecular Weight: 578.690940 g/mol
Molecular Formula of Verodoxin (CAS NO.6875-10-1 ) : C31H46O10
Structure of Verodoxin (CAS NO.6875-10-1 ) :
1. | orl-mus LD50:51,870 µg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 153 (1965),436. | ||
2. | scu-mus LD50:2890 µg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 153 (1965),436. | ||
3. | ivn-cat LDLo:231 µg/kg | JMPCAS Journal of Medicinal and Pharmaceutical Chemistry. 5 (1962),988. | ||
4. | orl-gpg LDLo:2370 µg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 153 (1965),436. | ||
5. | ivn-gpg LDLo:237 µg/kg | AIPTAK Archives Internationales de Pharmacodynamie et de Therapie. 153 (1965),436. |
Verodoxin (CAS NO.6875-10-1 ) is poison by ingestion, subcutaneous, and intravenous routes.
Classification Code of Verodoxin (CAS NO.6875-10-1 ) : Drug / Therapeutic Agent